Townsend & Associates
BMY icon

Townsend & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Townsend & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.62M Sell
43,789
-2,109
-5% -$133K 0.22% 52
2026
Q2 		$2.76M Sell
45,898
-547
-1% -$31.4K 0.24% 52
2026
Q1 		$2.73M Sell
46,445
-322
-0.7% -$18.8K 0.24% 51
2025
Q4 		$2.65M Sell
46,767
-1,405
-3% -$67.6K 0.24% 50
2025
Q3 		$2.1M Buy
48,172
+39
+0.1% +$1.82K 0.2% 53
2025
Q2 		$2.33M Buy
48,133
+791
+2% +$38.8K 0.23% 49
2025
Q1 		$2.32M Buy
47,342
+2,817
+6% +$164K 0.24% 48
2024
Q4 		$2.54M Sell
44,525
-124
-0.3% -$6.93K 0.26% 49
2024
Q3 		$2.37M Buy
44,649
+1,051
+2% +$49.3K 0.24% 49
2024
Q2 		$2.2M Buy
43,598
+472
+1% +$21.1K 0.24% 48
2024
Q1 		$2.11M Buy
43,126
+3,070
+8% +$156K 0.25% 48
2023
Q4 		$2.01M Sell
40,056
-2,154
-5% -$113K 0.25% 48
2023
Q3 		$2.15M Sell
42,210
-1,640
-4% -$100K 0.45% 46
2023
Q2 		$2.8M Sell
43,850
-252
-0.6% -$16.9K 0.72% 45
2023
Q1 		$2.94M Buy
44,102
+17,422
+65% +$1.23M 1.18% 30
2022
Q4 		$1.95M Buy
26,680
+5,364
+25% +$404K 0.97% 39
2022
Q3 		$1.7M Buy
21,316
+3,934
+23% +$285K 0.79% 45
2022
Q2 		$1.31M Buy
+17,382
New +$1.32M 0.61% 58

Other funds holding BMY

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Townsend & Associates's BMY Position: Q3 2026 in Review

Townsend & Associates reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2026, selling an estimated $133K and leaving 43,789 shares worth $2.62M. The position accounts for 0.22% of the portfolio, ranked #52.

Townsend & Associates first reported a position in BMY in Q2 2022 and has held it in 18 quarters since. The position peaked at $2.94M in Q1 2023. 1,093 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Townsend & Associates held 43,789 shares of Bristol-Myers Squibb worth $2.62M as of Q3 2026.
  • Townsend & Associates sold 2,109 Bristol-Myers Squibb shares in Q3 2026, an estimated $133K.
  • Bristol-Myers Squibb made up 0.22% of Townsend & Associates's portfolio in Q3 2026, its #52 holding.
  • Townsend & Associates first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 18 quarters since.
  • Townsend & Associates's Bristol-Myers Squibb position peaked at $2.94M in Q1 2023.
  • 1,093 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Townsend & Associates's 13F filing for Q3 2026, filed 23 Oct 2026.